<!DOCTYPE html>
<html lang="en" class="dark">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>MDC Library | MetalDrug</title>
  <script src="https://cdn.tailwindcss.com"></script>
</head>
<body class="bg-gray-950 text-gray-200 font-mono">
  <header class="p-6 text-center border-b border-gray-800">
    <h1 class="text-3xl font-bold text-white">Metal-Drug Complex (MDC) Library</h1>
    <p class="text-gray-400 mt-2">Explore our prototype complexes and therapeutic innovations.</p>
  </header>

  <section class="p-6 max-w-5xl mx-auto grid grid-cols-1 sm:grid-cols-2 gap-6">
    <a href="ga3-ciprofloxacin.html" class="block bg-gray-800 p-4 rounded-lg border border-gray-700 hover:border-blue-500 transition">
      <h2 class="text-xl font-bold text-white">Ga³⁺-Ciprofloxacin</h2>
      <p class="text-gray-400 text-sm">Antibacterial complex with enhanced uptake and membrane disruption activity. Shown to reduce resistance emergence.</p>
    </a>
    <a href="cu2-histidine.html" class="block bg-gray-800 p-4 rounded-lg border border-gray-700 hover:border-blue-500 transition">
      <h2 class="text-xl font-bold text-white">Cu²⁺-Histidine</h2>
      <p class="text-gray-400 text-sm">Anti-inflammatory scaffold with ROS-responsive redox behavior. Designed for timed release in oxidative environments.</p>
    </a>
    <a href="zn2-ivermectin.html" class="block bg-gray-800 p-4 rounded-lg border border-gray-700 hover:border-blue-500 transition">
      <h2 class="text-xl font-bold text-white">Zn²⁺-Ivermectin</h2>
      <p class="text-gray-400 text-sm">Antiviral MDC prototype enhancing protein binding affinity and oral bioavailability. Targets cytoplasmic viral proteins.</p>
    </a>
    <a href="ru4-doxorubicin.html" class="block bg-gray-800 p-4 rounded-lg border border-gray-700 hover:border-blue-500 transition">
      <h2 class="text-xl font-bold text-white">Ru⁴⁺-Doxorubicin</h2>
      <p class="text-gray-400 text-sm">Oncology-targeted agent with pH-activated cytotoxicity. Stable at blood pH, active in acidic tumor microenvironments.</p>
    </a>
    <a href="fe2-ribavirin.html" class="block bg-gray-800 p-4 rounded-lg border border-gray-700 hover:border-blue-500 transition">
      <h2 class="text-xl font-bold text-white">Fe²⁺-Ribavirin</h2>
      <p class="text-gray-400 text-sm">Proposed MDC for viral hepatitis with iron-mediated targeting of hepatic enzymes. Enhances metabolic stability.</p>
    </a>
    <a href="bi3-minocycline.html" class="block bg-gray-800 p-4 rounded-lg border border-gray-700 hover:border-blue-500 transition">
      <h2 class="text-xl font-bold text-white">Bi³⁺-Minocycline</h2>
      <p class="text-gray-400 text-sm">Neuroprotective prototype designed for spinal cord injury and CNS repair. Evaluated for axon regeneration pathways.</p>
    </a>
  </section>

  <div class="text-center mt-10">
    <a href="index.html" class="text-sm text-blue-400 underline">← Back to MDC Home/index</a>
  </div>

  <footer class="text-center p-6 border-t border-gray-800 text-gray-600 text-sm mt-10">
    © 2025 Kunfirm Technologies. All Rights Reserved. MDC Platform is part of the KT Biotech initiative.
  </footer>
</body>
</html>
